Newsroom

Categories: Drug Discovery & Development, Pharma, Corporate, Finance & Investor

Sygnature Discovery & RenaSci strengthen in vivo pharmacology service-offering

May 29, 2019

Categories: Omics & Genetics, Biotechnology, Drug Discovery & Development, Pharma, Clinical Research & Trials

Loop Genomics launches four new Microbiome kits

May 28, 2019

Categories: Computing & Technology, Corporate, Finance & Investor

BioCity invests in tech start-up INCUS Performance

May 2, 2019

Categories: Biotechnology, Pharma, Corporate, Finance & Investor

NanoFCM opens European office & centre of excellence for scientific application support

April 30, 2019

Categories: Biotechnology, Energy & Environment, Corporate, Finance & Investor

BioCity invests in carbon recycling start-up, Deep Branch Biotechnology

April 24, 2019

Categories: Biomanufacturing, Biotechnology, Diagnostics & Hospital Laboratory, Drug Discovery & Development, Pharma, Veterinary

Jackson ImmunoResearch launches secondary antibodies for VHH discovery

April 17, 2019

Categories: Biotechnology, Computing & Technology, Drug Discovery & Development, Pharma, Corporate, Finance & Investor

Sygnature Discovery announces collaboration with software firm SilcsBio

April 17, 2019

Categories: Biotechnology, Drug Discovery & Development, Pharma, Corporate, Finance & Investor

Senior appointments enhance Sygnature Discovery’s DMPK capabilities

March 21, 2019

Categories: Biotechnology, Drug Discovery & Development, Pharma, Corporate, Finance & Investor

Sygnature Discovery continues strong growth trajectory with two senior appointments

February 15, 2019